AbbVie Inc. (ABBV)
AbbVie Max Pain By Strike
ABBV trades at $212.43, 2.4% above the near-term max pain of $207.5 expiring Sep 5, 2025 (0 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($140-$210), signaling increased put positioning or downside protection. Key magnetic zone at 190 where 5 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
AbbVie Max Pain By Expiry
Max pain for ABBV shows a downward trend from 210 to 140, indicating bearish sentiment or hedging activity. The 37% spread signals divergent expectations across timeframes. Most levels below 212.43 may cap rallies. Strong magnetic level at 190 (5 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 5, 2025 | 207.5 | -4.93 (-2.32%) |
| Sep 12, 2025 | 207.5 | -4.93 (-2.32%) |
| Sep 19, 2025 | 190 | -22.43 (-10.56%) |
| Sep 26, 2025 | 205 | -7.43 (-3.50%) |
| Oct 3, 2025 | 205 | -7.43 (-3.50%) |
| Oct 10, 2025 | 210 | -2.43 (-1.14%) |
| Oct 17, 2025 | 200 | -12.43 (-5.85%) |
| Oct 24, 2025 | 140 | -72.43 (-34.10%) |
| Nov 21, 2025 | 190 | -22.43 (-10.56%) |
| Dec 19, 2025 | 190 | -22.43 (-10.56%) |
| Jan 16, 2026 | 180 | -32.43 (-15.27%) |
| Feb 20, 2026 | 195 | -17.43 (-8.21%) |
| Mar 20, 2026 | 200 | -12.43 (-5.85%) |
| Jun 18, 2026 | 190 | -22.43 (-10.56%) |
| Sep 18, 2026 | 185 | -27.43 (-12.91%) |
| Oct 16, 2026 | 190 | -22.43 (-10.56%) |
| Jan 15, 2027 | 175 | -37.43 (-17.62%) |